Patients with HPV-positive oropharyngeal cancer may not require post-radiation surgery
the ONA take:
According to new findings presented at the American Society for Radiation Oncology's (ASTRO) 56th Annual Meeting in San Francisco, California, patients with human papillomavirus (HPV)-positive oropharyngeal cancer may not require neck surgery after receiving radiation therapy and chemotherapy.
In the study, researchers at Fox Chase Cancer Center in Philadelphia, Pennsylvania, analyzed the medical records of 396 patients with at least locally advanced oropharyngeal cancer. Of those, the records of 99 patients indicated whether or not their cancer had likely been activated by HPV, and 146 patients underwent neck surgery within 180 days after the completion of radiation therapy.
The researchers found that patients with HPV-positive oropharygneal cancer were most likely to respond better to treatment compared with those with HPV-negative cancer. This trend has also been seen in previous studies. Patients who were found to have a protein called p16, an indicator of HPV-positive cancer, were less likely to experience a recurrence of their cancer.
Patients with HPV-positive cancer who elected to undergo neck surgery were more likely to have benign bumps, while those uninfected by HPV who underwent neck surgery were more likely to have malignant bumps.
HPV-positive oropharyngeal cancer may not require surgery after receiving radiation and chemo.
A new study shows that patients with human papillomavirus (HPV) – the same virus associated with both cervical and head and neck cancer – positive oropharyngeal cancer see significantly higher rates of complete response on a post-radiation neck dissection than those with HPV-negative oropharyngeal cancer.
Fox Chase Cancer Center researchers presented the findings at the American Society for Radiation Oncology's 56th Annual Meeting on Wednesday, September 17.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|